Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;

Achlorophyllic algae and chronic bursitis: An exceptional association Pablo González del Pozo; Paula Álvarez Peñalba; Stefanie Burger; Norma Alejandra Callejas Pineda; Rubén Queiro Silva; Sara Alonso Castro;

Does human microbiota interact with immunosuppressive treatment of systemic autoimmune rheumatological diseases? A systematic review Noemí Franco-Domingo; Patricia Saiz-López; Loreto Carmona-Ortells;